ClinicalTrialsFinder

HER2 Low Breast Adenocarcinoma Clinical Trials in Boston, Massachusetts

1 recruitingBoston, Massachusetts

Showing 1–1 of 1 trials

Recruiting
Phase 2

TRUDI: TDXD+Durva in HER2+/Low IBC

Breast CancerInvasive Breast CancerHER2-positive Breast Cancer+2 more
Filipa Lynce, MD63 enrolled3 locationsNCT05795101